tirzepatide journal club In the SURMOUNT-1 trial (published in NEJM in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor tirzepatide journal club Tirzepatide Journal

Most individuals adapt well to tirzepatide when dosing is increased slowly, and side effects tend to diminish after the first few dose escalations

Nrf2 can then translocate to the nucleus and bind to the antioxidant response element (ARE) located in the promoters of genes coding for antioxidant/detoxifying enzymes and scavengers

In addition, some individuals find it easier to maintain healthier eating habits because cravings become more manageable

The best time to consider surgery is when you have reached your goal weight and been stable for 2-3 months or more

The dose-response analysis determined an ED of 242.9 mg/kg and a maximum efficacy (E max ) of 54%, based on 1-h post-administration values [71]

Dr Cigdem Ozden was confidant in her work and the vibe was on point